Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature

Franco-Paredes, 2006, The ever-expanding association between rheumatologic diseases and tuberculosis, Am J Med, 119, 470, 10.1016/j.amjmed.2005.10.063 Kodali, 1998, Arthritis after BCG vaccine in a healthy woman, J Intern Med, 244, 183, 10.1046/j.1365-2796.1998.0371a.x Torisu, 1978, A new side effect of BCG immunotherapy. BCG-induced arthritis in man, Cancer Immunol Immunother, 5, 77, 10.1007/BF00199980 Lamm, 2000, Efficacy and safety of bacille Calmette–Guérin immunotherapy in superficial bladder cancer, Clin Infect Dis, 31, S86, 10.1086/314064 Luo, 2011, Th1 cytokine-secreting recombinant Mycobacterium bovis Bacillus Calmette–Guerin and prospective use in immunotherapy of bladder cancer, Clin Dev Immunol, 728930 Colmegna, 2004, HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations, Clin Microbiol Rev, 17, 348, 10.1128/CMR.17.2.348-369.2004 Tinazzi, 2006, Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review, Rheumatol Int, 26, 481, 10.1007/s00296-005-0059-2 Lamm, 1986, Complications of BCG immunotherapy in 1278 patients with bladder cancer, J Urol, 135, 272, 10.1016/S0022-5347(17)45606-0 Al, 1990, Bacillus Calmette–Guérin treatment of 39 patients with superficial transitional cell carcinoma of the bladder, Scand J Urol Nephrol, 25, 135 Kudo, 1991, Serious complications of intravesical bacillus Calmette–Guerin therapy in patients with bladder cancer, Nihon Hinyokika Gakkai Zasshi, 82, 1594 Lam, 2003, Bacillus Calmette–Guérin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity, Urol Oncol, 21, 354, 10.1016/S1078-1439(03)00012-7 Minei, 2004, Nippon Hinyokika Gakkai Zasshi, 95, 657 Koga, 2005, Adverse drug reactions of intravesical bacillus Calmette–Guérin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder, Int J Urol, 12, 145, 10.1111/j.1442-2042.2005.01000.x Clavel, 2006, Osteoarticular side effects of BCG therapy, Joint Bone Spine, 73, 24, 10.1016/j.jbspin.2004.12.003 Kuipers, 1999, Reactive or infectious arthritis, Ann Rheum Dis, 58, 661, 10.1136/ard.58.11.661 Toivanen, 2000, Reactive arthritis, Curr Opin Rheumatol, 12, 300, 10.1097/00002281-200007000-00012 Khan, 2002, Update on spondyloarthropathies, Ann Intern Med, 136, 896, 10.7326/0003-4819-136-12-200206180-00011 Hughes, 1989, Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder, Ann Rheum Dis, 48, 432, 10.1136/ard.48.5.432 Ochsenkühn, 1990, Arthritis after Mycobacterium bovis immunotherapy for bladder cancer, Ann Intern Med, 1, 882, 10.7326/0003-4819-112-11-882_2 Kudo, 1991, Serious complications of intravesical bacillus Calmette–Guerin therapy in patients with bladder cancer, Nihon Hinyokika Gakkai Zasshi, 82, 1594 Goupille, 1992, Arthritis after Calmette–Guerin bacillus immunotherapy for bladder cancer, J Rheumatol, 19, 1825 Puett, 1992, Arthritis after Bacillus Calmette–Guerin therapy, Ann Intern Med, 117, 537, 10.7326/0003-4819-117-6-537_1 Chapman, 1992, Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder, N Z Med J, 105, 37 Belmatoug, 1993, Polyarthrite chez quatre patients traites par BCG-therapie intravesicale pour carcinome de la vessie, Rev Rhum, 60, 162 Faus, 1993, Reiter's syndrome after administration of intravesical bacille Calmette–Guérin, Clin Infect Dis, 17, 526, 10.1093/clinids/17.3.526 Jawad, 1993, Reactive arthritis associated with Bacillus Calmette–Guerin immunotherapy for carcinoma of the bladder: a report of two cases, Br J Rheumatol, 32, 1018, 10.1093/rheumatology/32.11.1018 Pancaldi, 1993, Reiter's syndrome after intravesical Bacillus Calmette–Guérin treatment for superficial bladder carcinoma, Br J Rheumatol, 32, 1096, 10.1093/rheumatology/32.12.1096 Xerri, 1993, Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder, Eur J Med, 2, 503 Nesher, 1993, Reiter syndrome after intravesical BCG therapy, Rev Rhum Ed Fr, 60, 941 Ortí, 1993, Intravesical BCG and arthritis, Med Clin (Barc), 100, 158 Price, 1994, Arthritis and iritis after BCG therapy for bladder cancer, J Rheumatol, 21, 564 Goupille, 1994, Three cases of arthritis after BCG therapy for bladder cancer, Clin Exp Rheumatol, 12, 195 Devlin, 1994, Arthritis as a complication of intravesical BCG vaccine, BMJ, 308, 1638, 10.1136/bmj.308.6944.1638 de Torres, 1994, Polyarthritis as a complication of the treatment with intravesical BCG, Med Clin (Barc), 102, 556 Varoqua, 1994, Polyarthritis in an elderly man with bladder cancer, Hosp Pract (Off Ed), 29, 75, 10.1080/21548331.1994.11443033 Thepot, 1995, Acute polyarthritis after BCG-therapy for bladder carcinoma in a patient with ankylosing spondylitis, Rev Rhum Engl Ed, 62, 459 Queiro, 1995, Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma, Br J Rheumatol, 34, 1097, 10.1093/rheumatology/34.11.1097 Hammadeh, 1995, Acute reactive polyarthritis after intravesical Bacillus Calmette–Guérin instillation, Br J Urol, 76, 811, 10.1111/j.1464-410X.1995.tb00788.x Missioux, 1995, Arthritis and iritis after Bacillus Calmette–Guérin therapy, J Rheumatol, 22, 2010 Miossec, 1996, Reactive arthritis associated with Bacillus Calmette–Guérin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens, J Rheumatol, 23, 1485 Saporta, 1996, Reiter syndrome following intracavitary BCG administration, Scand J Urol Nephrol, 31, 211, 10.3109/00365599709070334 Rødevand, 1996, Arthritis after BCG treatment of bladder cancer. A rare complication, Tidsskr Nor Laegeforen, 116, 3231 Smith, 1997, Synovial membrane cytokine profiles in reactive arthritis secondary to intravesical Bacillus Calmette–Guérin therapy, J Rheumatol, 24, 752 Hansen, 1997, Epididymo-orchitis and Reiter's disease. Two infrequent complications after intravesical Bacillus Calmette–Guerin therapy, Scand J Urol Nephrol, 31, 317, 10.3109/00365599709070359 Fond, 1998, Acute oligo-arthritis in a patient treated with BCG therapy for bladder carcinoma, Presse Med, 27, 475 Schwartzenberg, 1999, Bacillus Calmette–Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy, J Rheumatol, 26, 933 Gillet, 1998, Complications systemiques de la BCG therapie intrave: 2 nouvelles observations, Therapie, 53, 190 Milas, 1999, Refractory arthropathy after intravesical Bacillus Calmette–Guerin therapy. Usefulness of isoniazide, Rev Rhum, 66, 106 Clavel, 1999, Polyarthritis following intravesical BCG immunotherapy, Rev Rhum, 66, 115 Onur, 1999, Polyarthritis as a complication of intravesical Bacillus Calmette–Guerin immunotherapy for bladder cancer, Clin Rheumatol, 18, 74, 10.1007/s100670050059 Chevrel, 1999, Severe uveitis followed by reactive arthritis after Bacillus Calmette–Guérin therapy, J Rheumatol, 26, 1011 Resel Folkersma, 1999, Reiter syndrome: atypical complication of treatment with BCG, Arch Esp Urol, 52, 1083 Varentsov, 1999, Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer, Urologiia, 29 Hogarth, 2000, Reiter's syndrome following intravesical BCG immunotherapy, Postgrad Med J, 76, 791, 10.1136/pmj.76.902.791 Hodish, 2000, Reiter's syndrome after intravesical Bacillus Calmette–Guérin therapy for bladder cancer, Isr Med Assoc J, 2, 240 Mouly, 2001, Remitting seronegative symmetrical synovitis with pitting edema following intravesical Bacillus Calmette–Guérin instillation, J Rheumatol, 28, 1699 Shoenfeld, 2001, BCG and autoimmunity: another two-edged sword, J Autoimmun, 16, 235, 10.1006/jaut.2000.0494 Bartolome Pacheco, 2002, Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid, Rheumatology, 41, 1119, 10.1093/rheumatology/41.10.1119 Pardalidis, 2002, Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer, Clin Rheumatol, 21, 536, 10.1007/s100670200131 Mas, 2002, Articular manifestations after the administration of intravesical BCG, Joint Bone Spine, 69, 92, 10.1016/S1297-319X(01)00350-5 Neumayr, 2002, Chronic reactive arthritis associated with Calmette–Guérin bacillus, Dtsch Med Wochenschr, 127, 1886, 10.1055/s-2002-34066 Pego, 2003, Relapsing Reiter's syndrome after Bacillus Calmette–Guérin immunotherapy for bladder carcinoma, Med Clin (Barc), 121, 356 Shiba, 2003, Reiter syndrome after intravesical Bacillus Calmette–Guerin (BCG) immunotherapy: a case report, Hinyokika Kiyo, 49, 599 Minei, 2004, Arthritis following intravesical instillation of BCG for urothelial cancers, Nihon Hinyokika Gakkai Zasshi, 95, 657 Asayama, 2004, Polyarthritis caused by intravesical Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer, Nihon Naika Gakkai Zasshi, 93, 1000, 10.2169/naika.93.1000 Murata, 2004, Reiter's syndrome following intravesical bacille bilié de Calmette–Guerin treatment for superficial bladder carcinoma: report of six cases, Mod Rheumatol, 14, 82, 10.3109/s10165-003-0272-3 Tinazzi, 2005, Reactive arthritis following BCG immunotherapy for bladder carcinoma, Clin Rheumatol, 24, 425, 10.1007/s10067-004-1063-8 Manzini, 2006, Dattilite ed oligoartrite secondarie ad immunoterapia con BCG in un paziente con carcinoma vescicale, Reumatismo, 58, 230 El Mahou, 2006, Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation, Clin Rheumatol, 25, 566, 10.1007/s10067-005-0157-2 Bandinelli, 2006, Artrite reattiva da immunoterapia intravescicale con BCG; descrizione di un caso, Reumatismo, 58, 380 Moutzouris, 2006, Acute polyarthritis after bacilli Calmette–Guerin intravesical therapy for bladder carcinoma, J Clin Rheumatol, 12, 214, 10.1097/01.rhu.0000231379.70786.01 Henares García, 2006, Artritis reactiva secundaria a inmunoterapia intravesical con bacilo de Calmette–Guerin, Semergen, 32, 176, 10.1016/S1138-3593(06)73249-X Tektonidou, 2007, Reiter's syndrome during intravesical BCG therapy for bladder carcinoma, Clin Rheumatol, 26, 1368, 10.1007/s10067-006-0393-0 Rincón Mayans, 2007, Polyarthritis secondary to intravesical BCG instillation, a case report, Actas Urol Esp, 31, 400, 10.1016/S0210-4806(07)73655-0 Piras, 2007, Artrite reattiva a immunoterapia con BCG: a proposito di tre nuovi casi, Reumatismo, 59, 611 Valenzuela-Suárez, 2008, Paciente nasculino de 74 aňos de edad con hiperemia conjuntival bilateral, polaquiuria, disuria, dolor urente en el meato urinario, dolor lombar y artritis reactiva secondaria a aplicaciòn de la vacuna BCG, Gac Med Mex, 144, 345 Miranda, 2010, Acute reactive arthritis after intravesical instillation of Bacillus Calmette–Guérin. Two case reports and literature review, Rev Med Interne, 31, 558, 10.1016/j.revmed.2010.01.010 Macía Villa, 2012, Reactive arthritis after the intravesical instillation of BCG, Reumatol Clin, 8, 284, 10.1016/j.reuma.2011.11.009 Olfert, 2006, An update review of the literature: risk factors for bladder cancer with focus on occupational exposure, South Med J, 99, 1256, 10.1097/01.smj.0000247266.10393.72 Ferlay, 2008 Hannu, 2002, Campylobacter-triggered reactive arthritis: a population-based study, Rheumatology, 41, 312, 10.1093/rheumatology/41.3.312 Locht, 1993, Reactive arthritis after Salmonella among medical doctors—study of an outbreak, J Rheumatol, 20, 845 Laitenen, 1972, Polyarthritis associated with Yersinia enterocolitica infection. Clinical features and laboratory findings in nine cases with severe joint symptoms, Ann Rheum Dis, 31, 34, 10.1136/ard.31.1.34 Ahvonen, 1969, Arthritis associated with Yersinia enterocolitica infection, Acta Rheum Scand, 15, 232, 10.3109/rhe1.1969.15.issue-1-4.32 Petersel, 2005, Reactive arthritis, Infect Dis Clin N Am, 19, 863, 10.1016/j.idc.2005.07.001 Hannu, 2011, Reactive arthritis, Best Pract Res Clin Rheumatol, 25, 347, 10.1016/j.berh.2011.01.018 Mattila, 1998, Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection, J Infect, 36, 289, 10.1016/S0163-4453(98)94243-8 Kvien, 1994, Reactive arthritis: incidence, triggering agents and clinical presentation, J Rheumatol, 21, 115 Ozgül, 2006, Clinical presentations of chlamydial and non-chlamydial reactive arthritis, Rheumatol Int, 26, 879, 10.1007/s00296-005-0094-z Kobayashi, 2005, Reactive arthritis: recent advances and clinical manifestations, Intern Med, 44, 408, 10.2169/internalmedicine.44.408 Sieper, 1996, Aetiological agents and immune mechanisms in enterogenic reactive arthritis, Baillieres Clin Rheumatol, 10, 105, 10.1016/S0950-3579(96)80008-2 Leirisalo-Repo, 2003, Microbial factors in spondyloarthropathies: insights from population studies, Curr Opin Rheumatol, 15, 408, 10.1097/00002281-200307000-00006 Sieper, 2002, Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays, Arthritis Rheum, 46, 319, 10.1002/art.504